======= TRA2A ======= == Gene Information == * **Official Symbol**: TRA2A * **Official Name**: transformer 2 alpha homolog * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29896|29896]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13595|Q13595]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRA2A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRA2A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602718|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing. {ECO:0000269|PubMed:9546399}. |RRM 1| |positive regulation of mRNA splicing, via spliceosome| |positive regulation of mRNA processing| |positive regulation of RNA splicing| |positive regulation of mRNA metabolic process| |regulation of mRNA splicing, via spliceosome| |regulation of RNA splicing| |regulation of mRNA processing| |ribonucleoprotein complex| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |regulation of mRNA metabolic process| |RNA splicing| |mRNA processing| |intracellular membrane-bounded organelle| |mRNA metabolic process| |nucleolus| |RNA processing| |RNA binding| |RNA metabolic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.08| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.84| |[[:results:exp180|Dynasore 10μM R04 exp180]]|1.7| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|1.72| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.75| |[[:results:exp93|DABN racemic mixture R03 exp93]]|1.75| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|1.78| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.88| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.96| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.07| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.2| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.22| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.4| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.54| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.88| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.521| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16283 * **Expression level (log2 read counts)**: 7.32 {{:chemogenomics:nalm6 dist.png?nolink |}}